Related Experiment Video

Updated: Aug 8, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Pleural fibrosis

Michael A Jantz1, Veena B Antony

  • 1Division of Pulmonary and Critical Care Medicine, University of Florida, 1600 SW Archer Road, Room M352, PO Box 100225, Gainesville, FL 32610-0225, USA. jantzma@medicine.ufl.edu

Clinics in Chest Medicine
|May 24, 2006
PubMed

Insights

Pleural fibrosis, a scarring of the lung lining, arises from inflammation. Understanding pleural mesothelial cell responses and mediators like cytokines is key to preventing this condition and its rare complications, fibrothorax and trapped lung.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Pathology

Background:

  • Pleural fibrosis results from inflammatory processes affecting the lung lining.
  • The pleural mesothelial cell's response to injury is critical in determining healing versus fibrosis.
  • Cytokines and abnormal fibrin turnover play roles in pleural fibrosis pathogenesis.

Purpose of the Study:

  • To examine the roles of key mediators in pleural fibrosis development.
  • To review common clinical conditions leading to pleural fibrosis.
  • To discuss the management of pleural fibrosis and its rare consequences.

Main Methods:

  • Review of existing literature on pleural fibrosis.
  • Analysis of the role of pleural mesothelial cells and cytokines.
  • Examination of fibrin turnover in pathogenesis.

Main Results:

  • Pleural mesothelial cell integrity is crucial for normal healing.
  • Specific cytokines and disordered fibrin turnover contribute to fibrosis.
  • Fibrothorax and trapped lung are uncommon but significant outcomes.

Conclusions:

  • Understanding cellular and molecular mechanisms is vital for preventing pleural fibrosis.
  • Clinical conditions associated with fibrosis require careful management.
  • Management strategies for pleural fibrosis, fibrothorax, and trapped lung are discussed.

More Related Videos

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

Related Concept Videos

Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleura of the Lungs01:13

Pleura of the Lungs

The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations: